Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs TRU✓SelectedUSD · TRUGSK vs TRU performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs TRU

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
TRU return
+30.1%
Excess return
+22.6%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioTRUExcessAlpha
1D-0.1%-0.1%0.0%-0.1%
7D-5.3%-8.2%+2.9%-4.5%
30D-3.7%-5.6%+1.9%-3.1%
3M-7.3%-12.4%+5.2%-6.2%
6M-4.2%+8.5%-12.7%-4.9%
YTD+0.9%-12.7%+13.5%+1.5%
1Y+7.3%-7.1%+14.4%+7.3%
3Y+52.7%+26.2%+26.6%+45.3%
All+52.7%+30.1%+22.6%+45.3%

Cumulative growth

Daily Returns

Daily percentage return beside TRU.

Daily Out/Under-Performance

Portfolio return minus TRU return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × TRU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded TRU wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling